ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide.
ConvaTec Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£2.03|
|52 Week High||UK£1.78|
|52 Week Low||UK£2.65|
|1 Month Change||-8.41%|
|3 Month Change||-22.38%|
|1 Year Change||9.51%|
|3 Year Change||31.13%|
|5 Year Change||-18.96%|
|Change since IPO||-9.96%|
Recent News & Updates
Estimating The Intrinsic Value Of ConvaTec Group Plc (LON:CTEC)
How far off is ConvaTec Group Plc ( LON:CTEC ) from its intrinsic value? Using the most recent financial data, we'll...
Is ConvaTec Group (LON:CTEC) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
ConvaTec Group (LON:CTEC) Has Affirmed Its Dividend Of UK£0.012
The board of ConvaTec Group Plc ( LON:CTEC ) has announced that it will pay a dividend of UK£0.012 per share on the...
ConvaTec Group's (LON:CTEC) Returns On Capital Are Heading Higher
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
|CTEC||GB Medical Equipment||GB Market|
Return vs Industry: CTEC exceeded the UK Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: CTEC underperformed the UK Market which returned 23.2% over the past year.
Stable Share Price: CTEC is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: CTEC's weekly volatility (3%) has been stable over the past year.
About the Company
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes.
ConvaTec Group Fundamentals Summary
|CTEC fundamental statistics|
Is CTEC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CTEC income statement (TTM)|
|Cost of Revenue||US$910.30m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.069|
|Net Profit Margin||6.98%|
How did CTEC perform over the long term?See historical performance and comparison
2.0%Current Dividend Yield
Is ConvaTec Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CTEC (£2.03) is trading below our estimate of fair value (£2.93)
Significantly Below Fair Value: CTEC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CTEC is poor value based on its PE Ratio (40.3x) compared to the UK Medical Equipment industry average (28.3x).
PE vs Market: CTEC is poor value based on its PE Ratio (40.3x) compared to the UK market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: CTEC is poor value based on its PEG Ratio (2x)
Price to Book Ratio
PB vs Industry: CTEC is good value based on its PB Ratio (3.3x) compared to the GB Medical Equipment industry average (4x).
How is ConvaTec Group forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CTEC's forecast earnings growth (19.9% per year) is above the savings rate (0.9%).
Earnings vs Market: CTEC's earnings (19.9% per year) are forecast to grow faster than the UK market (12.8% per year).
High Growth Earnings: CTEC's earnings are forecast to grow, but not significantly.
Revenue vs Market: CTEC's revenue (4.1% per year) is forecast to grow slower than the UK market (5% per year).
High Growth Revenue: CTEC's revenue (4.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CTEC's Return on Equity is forecast to be low in 3 years time (17.7%).
How has ConvaTec Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CTEC has high quality earnings.
Growing Profit Margin: CTEC's current net profit margins (7%) are higher than last year (1.3%).
Past Earnings Growth Analysis
Earnings Trend: CTEC has become profitable over the past 5 years, growing earnings by 29.1% per year.
Accelerating Growth: CTEC's earnings growth over the past year (470.5%) exceeds its 5-year average (29.1% per year).
Earnings vs Industry: CTEC earnings growth over the past year (470.5%) exceeded the Medical Equipment industry 97.5%.
Return on Equity
High ROE: CTEC's Return on Equity (8.1%) is considered low.
How is ConvaTec Group's financial position?
Financial Position Analysis
Short Term Liabilities: CTEC's short term assets ($1.1B) exceed its short term liabilities ($455.5M).
Long Term Liabilities: CTEC's short term assets ($1.1B) do not cover its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: CTEC's debt to equity ratio (84.8%) is considered high.
Reducing Debt: CTEC had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: CTEC's debt is well covered by operating cash flow (25.9%).
Interest Coverage: CTEC's interest payments on its debt are well covered by EBIT (6.8x coverage).
What is ConvaTec Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CTEC's dividend (1.96%) is higher than the bottom 25% of dividend payers in the UK market (1.4%).
High Dividend: CTEC's dividend (1.96%) is low compared to the top 25% of dividend payers in the UK market (4.06%).
Stability and Growth of Payments
Stable Dividend: CTEC has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: CTEC's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (82%), CTEC's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CTEC's dividends in 3 years are forecast to be well covered by earnings (41.2% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Karim Bitar (56 yo)
Mr. Karim Bitar serves as Chief Executive Officer and Director at Convatec Group Plc since September 30, 2019. Mr. Bitar served as the Chief Executive Officer of Genus plc from September 30, 2011 to Septem...
CEO Compensation Analysis
Compensation vs Market: Karim's total compensation ($USD3.80M) is above average for companies of similar size in the UK market ($USD2.22M).
Compensation vs Earnings: Karim's compensation has been consistent with company performance over the past year.
Experienced Management: CTEC's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Experienced Board: CTEC's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CTEC insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
ConvaTec Group Plc's employee growth, exchange listings and data sources
- Name: ConvaTec Group Plc
- Ticker: CTEC
- Exchange: LSE
- Founded: 1978
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: UK£4.077b
- Shares outstanding: 2.01b
- Website: https://www.convatecgroup.com
Number of Employees
- ConvaTec Group Plc
- 3 Forbury Place
- 23 Forbury Road
- RG1 3JH
- United Kingdom
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/25 21:41|
|End of Day Share Price||2021/10/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.